Merck Serono, the biopharmaceutical division of Merck, and Biopharm GmbH have announced a research collaboration directed towards the molecular engineering of a biologic compound for the treatment ...

No cruel intentions here: Merck KGaA’s U.S. pharma arm has recruited ... She’ll now continue to share her experiences through EMD Serono’s ongoing “I’m Ready” campaign.

with the German firm’s Merck Serono division licensing various technologies used to engineer T-cells to target cancers, including its RheoSwitch platform for controlling gene expression and ...

Dr Reddy's, Merck Serono in pact to develop biotech drugs Germany's Merck KGaA, have entered into a partnership to co-develop a portfolio of biosimilar compounds (biotechnology drugs) in the ...